Veteran center Brian Boyle discusses why he signed with the Devils and the expectations for this season. Andrew Gross/NorthJersey.com
Brian Boyle has every intention of playing in the Devils’ regular-season opener on Oct. 7.
And he hopes Tuesday’s news that he has been diagnosed with chronic myeloid leukemia, a form of bone marrow cancer, is a topic of discussion for only a short time before he starts fielding hockey questions again.
“Hopefully this season can go as normal and regular as possible,” Boyle, 32, said on a conference call. “If I [stink] one night, it’s because I [stink].”
Dr. Michael Farber, the medical director of executive health at Hackensack University Medical Center and the Devils’ team internist called Boyle’s CML “largely treatable and it appears to be early in the disease” adding he believes it can be “largely treatable with medication” rather than protocols with toxic side effects, such as chemotherapy.
Farber did not have a timetable for Boyle to begin treatments but added he hopes to have a specific course of treatment decided upon possibly over the “next few days.”
Boyle said he has been feeling fatigued this summer but chalked it up to having a 2-year-old and an infant while traveling between Florida, Boston and New Jersey. But bloodwork taken on Thursday when Boyle reported to Devils’ training camp for medical testing produced the diagnosis.
“He came to us in great shape, with relatively few symptoms,” Farber said.
The affable, 6-foot-7 Boyle from Hingham, Mass., the ex-Ranger who signed a two-year, $5.5 million deal after splitting last season between the Lightning and Maple Leafs, was very upbeat and with a very positive attitude on the conference call. A man who puts strong faith in his religion, Boyle spoke repeatedly of the prayers directed his way, starting with his wife, Lauren, and from friends and family in and out of the NHL. Boyle…